World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 54 2309 2077 1137 1011 122 14625

Susan P. Whitman publications per year

The chart shows the history of publications by Susan P. Whitman between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Susan P. Whitman published across 39 years, from 1987 to 2025, averaging 3.5 papers a year. Output peaked at 19 publications in 2013. 2 of the 138 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 19. Peak 19 publications in 2013. 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 2 publications 1998: 3 publications 1999: 1 publication 2000: 1 publication 2001: 2 publications 2002: 0 publications 2003: 3 publications 2004: 1 publication 2005: 9 publications 2006: 3 publications 2007: 14 publications 2008: 13 publications 2009: 8 publications 2010: 13 publications 2011: 10 publications 2012: 15 publications 2013: 19 publications 2014: 6 publications 2015: 3 publications 2016: 3 publications 2017: 0 publications 2018: 1 publication 2019: 0 publications 2020: 0 publications 2021: 0 publications 2022: 0 publications 2023: 5 publications 2024: 0 publications 2025: 2 publications
1987 2025

138 publications in total across all disciplines

View publications per year as a table
Susan P. Whitman: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 0
1997 2
1998 3
1999 1
2000 1
2001 2
2002 0
2003 3
2004 1
2005 9
2006 3
2007 14
2008 13
2009 8
2010 13
2011 10
2012 15
2013 19
2014 6
2015 3
2016 3
2017 0
2018 1
2019 0
2020 0
2021 0
2022 0
2023 5
2024 0
2025 2
Total 138
Download as CSV

Susan P. Whitman publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Susan P. Whitman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 117–126 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 122 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177 122
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Susan P. Whitman D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Susan P. Whitman sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 54–55 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 54 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116 54
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Best Publications

  • IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

    Guido Marcucci;Kati Maharry;Yue-Zhong Wu;Michael D. Radmacher

  • Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study

    Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus

  • Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

    Krzysztof Mrózek;Guido Marcucci;Peter Paschka;Susan P. Whitman

  • MicroRNA expression in cytogenetically normal acute myeloid leukemia

    Guido Marcucci;Michael D. Radmacher;Michael D. Radmacher;Kati Maharry;Kati Maharry;Krzysztof Mrózek

  • Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

    Krzysztof Mrózek;Guido Marcucci;Deedra Nicolet;Kati S. Maharry

  • An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.

    Klaus H. Metzeler;Manuela Hummel;Clara D. Bloomfield;Karsten Spiekermann

  • Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study

    Heiko Becker;Guido Marcucci;Kati Maharry;Michael D. Radmacher

  • Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study

    Guido Marcucci;Kati Maharry;Michael D. Radmacher;Krzysztof Mrózek

  • TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

    Klaus H. Metzeler;Kati Maharry;Michael D. Radmacher;Krzysztof Mrózek

  • FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications

    Susan P. Whitman;Amy S. Ruppert;Amy S. Ruppert;Michael D. Radmacher;Michael D. Radmacher;Krzysztof Mrózek

  • ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

    Klaus H. Metzeler;Heiko Becker;Kati Maharry;Kati Maharry;Michael D. Radmacher;Michael D. Radmacher

  • Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia

    Guido Marcucci;Klaus H. Metzeler;Sebastian Schwind;Heiko Becker

  • RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

    Jason H. Mendler;Kati Maharry;Michael D. Radmacher;Krzysztof Mrózek

  • Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

    Peter Paschka;Guido Marcucci;Amy S. Ruppert;Susan P. Whitman

  • BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.

    Claudia D. Baldus;Stephan M. Tanner;Amy S. Ruppert;Susan P. Whitman

  • Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia

    Shujun Liu;Lai Chu Wu;Jiuxia Pang;Ramasamy Santhanam

  • Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study

    Guido Marcucci;Claudia D. Baldus;Amy S. Ruppert;Michael D. Radmacher

  • FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

    Susan P. Whitman;Kati Maharry;Kati Maharry;Michael D. Radmacher;Michael D. Radmacher;Heiko Becker

  • High Expression Levels of the ETS-Related Gene, ERG, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

    Guido Marcucci;Kati Maharry;Susan P. Whitman;Tamara Vukosavljevic

  • High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study

    Christian Langer;Michael D. Radmacher;Amy S. Ruppert;Susan P. Whitman

Frequent Co-Authors

Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Richard A. Larson
Richard A. Larson University of Chicago
Bayard L. Powell
Bayard L. Powell Wake Forest University
Maria R. Baer
Maria R. Baer University of Maryland, Baltimore
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham
Jonathan E. Kolitz
Jonathan E. Kolitz Hofstra University
Joseph O. Moore
Joseph O. Moore Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology can open doors to diverse and fast-growing career options, including clinical research, pharmaceuticals, and healthcare. Many students find that combining a scientific background with a health-focused degree increases versatility in the job market.

For those with nursing credentials, flexible online programs make advanced education more accessible. The fastest rn to bsn program online options are popular among working RNs looking to quickly upskill and move into more specialized roles. If you're considering becoming a nurse practitioner, exploring adn to np bridge programs might be the right step.

Even individuals without a nursing background and holding a molecular biology degree can transition rapidly through direct entry msn programs for non nurses online. These pathways allow non-nurses to access advanced nursing careers and leadership roles.

When choosing an online degree, comparing institutions is crucial. Reviews of capella vs wgu rn to bsn can help you identify the programs that best align with your career goals and learning preferences.

Best Scientists Citing Susan P. Whitman

Trending Scientists

Recently Published Articles